Clinical Trials on Anaplastic Oligodendroglioma - Clinical Trials Registry

NCT01847235

Completed

Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial

Conditions: Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
NCT00362570

Completed

Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma

Conditions: Oligoastrocytoma, Mixed; Anaplastic Oligodendroglioma
NCT00400816

Completed

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Conditions: Central Nervous System Tumors; Brain Tumor
NCT00003465

Completed

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Conditions: Brain and Central Nervous System Tumors
NCT00002569

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Conditions: Brain and Central Nervous System Tumors
NCT00033280

Completed

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Conditions: Brain and Central Nervous System Tumors
NCT00002840

Completed

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Conditions: Brain and Central Nervous System Tumors
NCT00588523

Active, not recruiting

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Conditions: CNS Cancer; CNS BRAIN
NCT02755987

No longer available

Expanded Access to ANG1005 for Individual Patients

Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Breast Cancer With Recurrent Brain Metastases; Leptomeningeal Carcinomatosis
NCT00303849

Recruiting

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Conditions: Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Mixed Glioma; Oligoastrocytoma
NCT00003101

Completed

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Conditions: Brain and Central Nervous System Tumors
NCT03353896

Withdrawn

NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma

Conditions: Anaplastic Oligodendroglioma; Oligoastrocytoma; Oligodendroglioma
NCT02871843

Active, not recruiting

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

Conditions: Glioblastoma; Oligodendroglioma; Anaplastic Oligodendroglioma
NCT00003372

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

Conditions: Brain and Central Nervous System Tumors
NCT01663012

Completed

Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Conditions: Anaplastic Astrocytomas; Anaplastic Oligodendrogliomas; Glioblastomas (GBM)
NCT00645385

Withdrawn

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma
NCT01644955

Completed

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Recurrent Adult Brain Tumor
NCT01985256

Completed

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
NCT01470794

Completed

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
NCT01156584

Completed

A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Conditions: Glioblastoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
NCT00734682

Completed

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

Conditions: Glioblastoma; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma
NCT00526812

Completed

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Conditions: Glioma
NCT03971734

Active, not recruiting

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Conditions: High Grade Glioma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioblastoma
NCT01656980

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Glioblastoma
NCT01637753

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Glioblastoma